02850-A: Potential Reduction of Systemic and Pancreatic Inflammation using Fenofibrate in Diabetic Dogs

Grant Status: Open

Grant Amount: $14,999
Chen Gilor, DVM, PhD; University of Florida
February 1, 2021 - June 30, 2024

Sponsor(s): American Miniature Schnauzer Club

Breed(s): -All Dogs
Research Program Area: Endocrinology
Donate to Support this Research Program Area


Diabetes mellitus (DM) is a common disease in dogs and a cause of significant patient morbidity as well as emotional and financial stress to pet owners. In this study, investigators will examine the effect of fenofibrate on alleviating some of the complications of DM. Fenofibrate is a drug known to decrease blood lipid levels that has also shown promise in laboratory settings to decrease other consequences of DM such as gut barrier dysfunction, systemic inflammation and pancreatitis. Investigators hypothesize that fenofibrate treatment in spontaneous canine DM will reduce systemic inflammation and decrease serum pancreatic lipase activity (a marker of pancreatic inflammation), and positively alter lipoprotein profiles without affecting blood sugar (glycemic) control. The results of this study will be used to design a larger long-term longitudinal clinical trial which will evaluate risk-reduction of pancreatitis and other DM complications by fenofibrate in dogs. 


None at this time.

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617

Tax ID# 13-3813813


© 2021 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.